Provided by Tiger Trade Technology Pte. Ltd.

Avalo Therapeutics Inc

19.74
+0.47002.44%
Post-market: 19.740.00000.00%16:41 EDT
Volume:1.02M
Turnover:19.92M
Market Cap:1.06B
PE:-4.48
High:20.05
Open:19.54
Low:19.36
Close:19.27
52wk High:24.27
52wk Low:8.65
Shares:53.63M
Float Shares:40.15M
Volume Ratio:1.24
T/O Rate:2.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4100
EPS(LYR):-5.8400
ROE:-36.27%
ROA:-18.50%
PB:2.36
PE(LYR):-3.38

Loading ...

May 12, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 05, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 28, 2026

Major Issues Report

Form 8-K - Current report
Apr 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 01, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Mar 27, 2026

Major Issues Report

Form 8-K - Current report
Mar 23, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 23, 2026

Major Issues Report

Form 8-K - Current report
Mar 23, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2026

Correspondence

Form CORRESP - Correspondence